首页> 美国卫生研究院文献>Blood >Image-guided intrathymic injection of multipotent stem cells supports lifelong T-cell immunity and facilitates targeted immunotherapy
【2h】

Image-guided intrathymic injection of multipotent stem cells supports lifelong T-cell immunity and facilitates targeted immunotherapy

机译:影像引导下的胸腺内多能干细胞注射支持终生T细胞免疫并促进靶向免疫治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

T-cell deficiency related to disease, medical treatment, or aging represents a major clinical challenge and is associated with significant morbidity and mortality in cancer and bone marrow transplantation recipients. This study describes several innovative and clinically relevant strategies to manipulate thymic function based on an interventional radiology technique for intrathymic injection of cells or drugs. We show that intrathymic injection of multipotent hematopoietic stem/progenitor cells into irradiated syngeneic or allogeneic young or aged recipients resulted in efficient and long-lasting generation of functional donor T cells. Persistence of intrathymic donor cells was associated with intrathymic presence of cells resembling long-term hematopoietic stem cells, suggesting a self-renewal capacity of the intrathymically injected cells. Furthermore, our approach enabled the induction of long-term antigen-specific T-cell–mediated antitumor immunity following intrathymic injection of progenitor cells harboring a transgenic T-cell receptor gene. The intrathymic injection of interleukin-7 prior to irradiation conferred radioprotection. In addition, thymopoiesis of aged mice improved with a single intrathymic administration of low-dose keratinocyte growth factor, an effect that was sustained even in the setting of radiation-induced injury. Taken together, we established a preclinical framework for the development of novel clinical protocols to establish lifelong antigen-specific T-cell immunity.
机译:与疾病,药物治疗或衰老相关的T细胞缺乏症是一项重大的临床挑战,并与癌症和骨髓移植受者的明显发病率和死亡率相关。这项研究描述了一种基于胸腺内注射细胞或药物的介入放射学技术来控制胸腺功能的几种创新且与临床相关的策略。我们表明胸腺内注射多能造血干/祖细胞到辐照的同基因或同种异体的年轻或老年接受者导致有效和持久的功能性供体T细胞生成。胸腺内供体细胞的持久性与胸腺内存在类似长期造血干细胞的细胞有关,表明胸腺内注射细胞的自我更新能力。此外,我们的方法能够在胸腺内注射含有转基因T细胞受体基因的祖细胞后,诱导长期的抗原特异性T细胞介导的抗肿瘤免疫。辐射前胸腺内注射白介素7可赋予放射防护作用。另外,通过一次低剂量角质形成细胞生长因子的胸腺内给药可改善衰老小鼠的胸腺细胞生成作用,即使在辐射致损伤的情况下,这种作用也得以持续。两者合计,我们建立了临床前框架,用于开发新的临床方案以建立终生抗原特异性T细胞免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号